arrow1 Comment
  1. Dr. Zoidberg
    Mar 23 - 9:48 am

    I tend to agree with Yamamoto that the current “collaboration” model doesn’t work. However, I’m also not sure if the new model will be better. It sounds better than the current model because students would actually be establishing contacts within the pharma industry rather than relying on the hollow promises of their PIs that finishing a 28 step synthesis of a natural product will guarantee them a job.

    However, given the current pharma mentality of “save money, efficiency/quality be damned”, grad students could very well get the shaft and still be unemployable at the end of their training. They’ll simply have contributed work to a project that can be outsourced.

    Change needs to occur on both sides of the table. I think UCSF is taking the right steps, but I’m highly skeptical that Pfizer or any other pharmas engaging in this are thinking of anything beyond the bottom line. It’s hard to find labor as inexpensive and hard-working as grad students, I have no confidence that these companies will just up and increase their pay 4 or 5-fold when these students graduate.

Mobile Theme